Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats
- PMID: 10340814
- DOI: 10.1038/sj.ijo.0800828
Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats
Abstract
Objective: To determine whether the slimming effects of treatment with oleoyl-estrone (OE) in liposomes of normal and obese rats are permanent, or disappear as soon as the treatment with the drug ceased. This study was devised to gain further knowledge on the postulated role of OE as a ponderostat signal, evaluating whether (in addition) it can lower the ponderostat setting of the rat.
Design: The rats were infused for 14d (using osmotic minipumps) with oleoyl-estrone in liposomes at a dose of 3.5 micromol/kg x d, and were studied up to one month after the treatment ceased.
Subjects: Young adult lean controls (CL) or treated (TL) and obese controls (CO) or treated (TO) Zucker rats.
Measurements: Energy balance, blood glucose, liver glycogen, plasma insulin, leptin corticosterone, ACTH and estrone (free and total) concentrations, and expression of the OB gene in white adipose tissue (WAT).
Results: The loss of body weight caused by OE was recovered quickly in the TO, which gained weight at the same rate as the CO. TL rats, however remained at the low weight attained for one month after the treatment ceased. However, no differences were observed in calculated energy expenditure (EE) between the TL and TC rats once treatment had stopped. In TL and TO rats, liver glycogen concentrations decreased to normal shortly after treatment ceased, and leptin expression and concentrations remained normal and unchanged after the end of OE treatment. In TO rats, plasma glucose, insulin and leptin were lower than in the CO. Total estrone concentrations decreased rapidly in TL rats and more slowly in the TO, and free estrone followed a similar pattern.
Conclusion: Continuous infusion of liposomes loaded with OE resulted in a decreased energy intake (EI), maintenance of EE and the utilization of body fat reserves in lean and obese rats alike. This process ended in obese rats as soon as the infusion ceased, so that even when the levels of free and total estrone in plasma remained high, there was a marked (and relatively fast) shift toward the basal situation, which translated into an increase in EI, maintenance of estimated EE and a marked buildup of energy stores. In lean rats, the effects of OE on leptin concentrations and OB gene expression persisted after infusion ended.
Similar articles
-
Effect of the slimming agent oleoyl-estrone in liposomes on the body weight of Zucker obese rats.Int J Obes Relat Metab Disord. 1997 Sep;21(9):789-95. doi: 10.1038/sj.ijo.0800475. Int J Obes Relat Metab Disord. 1997. PMID: 9376892
-
Oral oleoyl-estrone induces the rapid loss of body fat in Zucker lean rats fed a hyperlipidic diet.Int J Obes Relat Metab Disord. 2000 Nov;24(11):1405-12. doi: 10.1038/sj.ijo.0801393. Int J Obes Relat Metab Disord. 2000. PMID: 11126335
-
Effect of adrenalectomy on the slimming activity of liposome-carried oleoyl-estrone in the rat.Int J Obes Relat Metab Disord. 1998 Dec;22(12):1225-30. doi: 10.1038/sj.ijo.0800751. Int J Obes Relat Metab Disord. 1998. PMID: 9877258
-
Oleoyl-estrone.Med Res Rev. 2012 Nov;32(6):1263-91. doi: 10.1002/med.20240. Epub 2011 Feb 1. Med Res Rev. 2012. PMID: 21287573 Review.
-
Clinical aspects of leptin.Vitam Horm. 1998;54:1-30. doi: 10.1016/s0083-6729(08)60919-x. Vitam Horm. 1998. PMID: 9529971 Review.
Cited by
-
Estrogens and the regulation of glucose metabolism.World J Diabetes. 2021 Oct 15;12(10):1622-1654. doi: 10.4239/wjd.v12.i10.1622. World J Diabetes. 2021. PMID: 34754368 Free PMC article. Review.
-
Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.J Clin Med. 2014 Jul 15;3(3):763-94. doi: 10.3390/jcm3030763. J Clin Med. 2014. PMID: 26237477 Free PMC article. Review.
-
Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?Front Endocrinol (Lausanne). 2012 Feb 27;3:27. doi: 10.3389/fendo.2012.00027. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22649414 Free PMC article.
-
Regulation of appetite to treat obesity.Expert Rev Clin Pharmacol. 2011 Mar;4(2):243-59. doi: 10.1586/ecp.11.3. Expert Rev Clin Pharmacol. 2011. PMID: 21666781 Free PMC article. Review.
-
Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.Expert Rev Endocrinol Metab. 2010 Sep 1;5(5):765-783. doi: 10.1586/eem.10.33. Expert Rev Endocrinol Metab. 2010. PMID: 21297878 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous